Innovation is one potential tool for the healthcare systems to improve their efficiency by helping them successfully transform limited resources into valued outcomes
We proposed a taxonomy of nine barriers that can prevent the adoption of innovative health technologies in health systems. The barriers relate to 1) intrinsic properties of the innovation (e.g. technology barriers) 2) the health system’s ability to fund or integrate the innovation, and 3) the clinicians’ and patients’ readiness and willingness to engage with the innovation.
Overcoming barriers to the uptake of innovative technologies requires contribution from a wide spectrum of healthcare system stakeholders who can influence change.
Several multistakeholder partnerships have been implemented in the real world to address barriers to innovation adoption.
Partnerships can help overcome barriers to innovation uptake by removing silos, enhancing knowledge exchange, conducting additional research on technology and implementation, and influencing policy.
Partnerships should be considered when solutions require the pooling of knowledge across different stakeholders, when bringing innovation to patients safely and effectively requires coordination among different stakeholders, or to help overcome divergences in objectives/ incentives among various stakeholders.
Many healthcare systems globally are under pressure as they emerge from the COVID-19 pandemic. Poor economic conditions and escalating costs are placing additional financial burdens on public and private payers alike. Furthermore, a considerable amount of waste and inefficiency exists within these systems.
This report revisits the innovation-efficiency debate and acknowledges the contribution of innovation to efficiency in the context of growing pressures and limitations on health systems. Additionally, we discuss nine barriers that hinder realising more significant efficiency gains from innovation and consider how they can be overcome. The barriers concern the complete innovation adoption pathway, including regulatory, HTA & pricing, procurement, and clinical implementation phases.
Figure 1 Barriers that concern the innovation adoption pathway
Finally, we analyse the potential of stakeholder collaboration in overcoming the identified barriers to adopting health system innovation through case studies on multistakeholder partnerships, including the advanced therapy treatment centres (ATTC) network, Fast-Track Cities London, and the PrEP Think Tank initiative. Our analysis shows that multistakeholder partnerships should be considered when solutions require the pooling of knowledge across different stakeholders, when bringing innovation to patients safely and effectively requires coordination among different stakeholders, or to help overcoming divergences in objectives/ incentives among various stakeholders.as a solution to overcoming barriers that impede innovation adoption and efficiency improvements.
This report ‘’Innovation for Health System Efficiency and Improvement’’ was commissioned and funded by Gilead.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!